The effect of lycopene on cytochrome P450 isoenzymes and P-glycoprotein by using human liver microsomes and Caco-2 cell monolayer model

References

• Agarwal S, Rao AV. 2000. Tomato lycopene and its role in human health and chronic diseases. CMAJ. 16:739–744.
   Google Scholar
• Aman SF, Hassan F, Naqvi BS, Hasan SM. 2010. Studies of food drug interactions. Pak J Pharm Sci. 23:313–320.
   PubMed Web of Science ®Google Scholar
• Bailey DG. 2010. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol. 70:645–655.
   PubMed Web of Science ®Google Scholar
• Bhuvaneswari V, Nagini S. 2005. Lycopene: a review of its potential as an anticancer agent. Curr Med Chem Anticancer Agents. 5:627–635.
   PubMedGoogle Scholar
• Burton-Freeman B, Sesso HD. 2014. Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Adv Nutr. 5:457–485.
   PubMed Web of Science ®Google Scholar
• Bushra R, Aslam N, Khan AY. 2011. Food–drug interactions. Oman Med J. 26:77–83.
   PubMedGoogle Scholar
• Chen Y, Liu X, Pan R, Zhu X, Steinmetz A, Liao Y, Wang N, Peng B, Chang Q. 2013. Intestinal transport of 3,6’-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models. Planta Med. 79:1434–1439.
   PubMed Web of Science ®Google Scholar
• de Lemos ML, Hamata L, Jennings S, Leduc T. 2007. Interaction between mercaptopurine and milk. J Oncol Pharm Pract. 13:237–240.
   PubMedGoogle Scholar
• Elumalai P, Krishnamoorthy G, Selvakumar K, Arunkumar R, Venkataraman P, Arunakaran J. 2009. Studies on the protective role of lycopene against polychlorinated biphenyls (Aroclor 1254)-induced changes in StAR protein and cytochrome P450 scc enzyme expression on Leydig cells of adult rats. Reprod Toxicol. 27:41–45.
   PubMed Web of Science ®Google Scholar
• Gajowik A, Dobrzynska MM. 2014. Lycopene - antioxidant with radioprotective and anticancer properties. A review. Rocz Panstw Zakl Hig. 65:263–271.
   PubMedGoogle Scholar
• Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. 2005. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 165:1095–1106.
   PubMed Web of Science ®Google Scholar
• Holzapfel NP, Holzapfel BM, Champ S, Feldthusen J, Clements J, Hutmacher DW. 2013. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int J Mol Sci. 14:14620–14646.
   PubMed Web of Science ®Google Scholar
• Ito K, Brown HS, Houston JB. 2004. Database analyses for the prediction of in vivo drug-drug interactions from in vitro data. Br J Clin Pharmacol. 57:473–486.
   PubMed Web of Science ®Google Scholar
• Jayawardena N, Watawana MI, Waisundara VY. 2015. Evaluation of the total antioxidant capacity, polyphenol contents and starch hydrolase inhibitory activity of ten edible plants in an in vitro model of digestion. Plant Foods Hum Nutr. 70:71–76.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim H. 2015. Anticancer Effect of Lycopene in Gastric Carcinogenesis. J Cancer Prev. 20:92–96.
   PubMedGoogle Scholar
• Koe XF, Tengku Muhammad TS, Chong AS, Wahab HA, Tan ML. 2014. Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug-food interaction prediction tool. Food Sci Nutr. 2:500–520.
   PubMedGoogle Scholar
• Ono M, Takeshima M, Nakano S. 2015. Mechanism of the Anticancer Effect of Lycopene (Tetraterpenoids). Enzymes. 37:139–166.
   PubMedGoogle Scholar
• Rao AV, Agarwal S. 2000. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr. 19:563–569.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Fragoso L, Martinez-Arismendi JL, Orozco-Bustos D, Reyes-Esparza J, Torres E, Burchiel SW. 2011. Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. J Food Sci. 76:R112–R124.
   PubMed Web of Science ®Google Scholar
• Seah TC, Tay YL, Tan HK, Muhammad TS, Wahab HA, Tan ML. 2015. Determination of CYP3A4 inducing properties of compounds using a laboratory-developed cell-based assay. Int J Toxicol. 34:454–468.
   PubMed Web of Science ®Google Scholar
• Sorensen JM. 2002. Herb–drug, food–drug, nutrient–drug, and drug–drug interactions: mechanisms involved and their medical implications. J Altern Complement Med. 8:293–308.
   PubMed Web of Science ®Google Scholar
• Stahl W, Sies H. 1996. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys. 336:1–9.
   PubMed Web of Science ®Google Scholar
• Sunaga K, Ohkawa K, Nakamura K, Ohkubo A, Harada S, Tsuda T. 2012. Mechanism-based inhibition of recombinant human cytochrome P450 3A4 by tomato juice extract. Biol Pharm Bull. 35:329–334.
   PubMed Web of Science ®Google Scholar
• Tokac M, Aydin S, Taner G, Ozkardes AB, Yavuz Taslipinar M, Dogan M, Basaran AN. 2015. Hepatoprotective and antioxidant effects of lycopene in acute cholestasis. Turk J Med Sci. 45:857–864.
   PubMed Web of Science ®Google Scholar
• Tsugane S, Sasazuki S. 2007. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 10:75–83.
   PubMed Web of Science ®Google Scholar
• Won CS, Oberlies NH, Paine MF. 2010. Influence of dietary substances on intestinal drug metabolism and transport. Curr Drug Metab. 11:778–792.
   PubMed Web of Science ®Google Scholar
• Won CS, Oberlies NH, Paine MF. 2012. Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. Pharmacol Ther. 136:186–201.
   PubMed Web of Science ®Google Scholar
• Xia J, Lin J, Zhu SY, Du ZH, Guo JA, Han ZX, Zhang Y. 2016. Lycopene protects against atrazine-induced hepatotoxicity through modifications of cytochrome P450 enzyme system in microsomes. Exp Toxicol Pathol. 68:223–231.
   PubMed Web of Science ®Google Scholar
• Ye LH, He XX, Kong LT, Liao YH, Pan RL, Xiao BX, Chang Q. 2014. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves. J Ethnopharmacol. 153:190–196.
   PubMed Web of Science ®Google Scholar
• Ye LH, Kong LT, Xiao BX, Wang Q, He XX, Chang Q. 2013. Simultaneous determination of the activities of five majorcytochrome P450 enzymes by an in vitro cocktail method coupled with LC–MS/MS assay. Chin J Pharmacovigilance. 10:263–268.
   Google Scholar
• Zhang H, Ya G, Rui H. 2017. Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42:1–10.
   PubMed Web of Science ®Google Scholar
• Zhang L, Reynolds KS, Zhao P, Huang SM. 2010. Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Toxicol Appl Pharmacol. 243:134–145.
   PubMed Web of Science ®Google Scholar
• Zhou H, Tong Z, McLeod JF. 2004. “Cocktail” approaches and strategies in drug development: valuable tool or flawed science? J Clin Pharmacol. 44:120–134.
   PubMed Web of Science ®Google Scholar